Last reviewed · How we verify

NCT05458050

An Investigation to Identify Subjects Admitted to Hospital With an Increased Risk of Developing Pressure Ulcers

Completed NA Last updated 25 August 2023
What this trial tests

NA trial testing PU sensor in Pressure Ulcer in 433 participants. Completed in 24 August 2023.

Timeline
1 September 2022
Primary endpoint
30 June 2023
24 August 2023

Quick facts

Lead sponsorPU sensor AB
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposeprevention
Enrollment433
Start date1 September 2022
Primary completion30 June 2023
Estimated completion24 August 2023
Sites3 locations across Sweden

Drugs / interventions tested

Conditions studied

Sponsor

PU sensor AB

Who can join

18 and older, any sex, with Pressure Ulcer. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

A double blind, non randomized, multicenter investigation

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Pressure Ulcer

Currently open trials in the same condition.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05458050.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing